Elysium Health is a consumer health company that wants to translate advances in science and technology into clinically validated health products that work. The company was founded in 2014 by Dr. Leonard Guarente—the director of The Paul F. Glenn Center for Biology of Aging Research at MIT. The company is also backed by several prestigious scientists from research institutions such as Harvard and Stanford.
The company’s premier and sole product is the dietary supplement, Basis. Basis was created based on over two decades of prior scientific research in the field of aging. It is a daily supplement meant to support overall cellular health through increasing levels of a coenzyme called NAD+.
NAD+ is present in our cells and is key to many cellular functions such as circadian rhythms, DNA maintenance, and energy creation. As we grow older NAD+ levels decrease naturally, subsequently affecting the processes which rely on the coenzyme. However, with a regular intake of Basis, consumers can increase and maintain higher NAD+ levels.
In 2016, Elysium Health funded a clinical study in order to prove the efficacy of Basis. Those who took a regular dose of the supplement for a month saw an average increase in NAD+ levels of 40 percent. These results were published in the online scientific journal npj: Aging and Mechanisms of Disease.
Part of an industry often criticized for ineffective products or outlandish claims, Elysium Health is not only redefining the supplement industry with its products but is also establishing credibility for its supplements.
Consumers can find options to purchase basis on the Elysium Health’s website. A one-time purchase of Basis costs $60 and includes a 30-day supply of the supplement. Monthly, six-month, and one-year subscriptions to Basis are also available for between $40-50 per month.
More information on Elysium Health, the company’s team, and the science behind Basis can be found on Elysium’s website.
Visit Elysium Health on Medium.com.